{"predictions":[{"id":"20260403T210606-7e98c538::gantenerumab::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"GANTENERUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::rivastigmine::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::galantamine::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::donepezil::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::solanezumab::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"SOLANEZUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::lecanemab::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::aducanumab::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::nirogacestat::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210606-7e98c538::donanemab::alzheimers_disease","analysisId":"20260403T210606-7e98c538","recordedAt":"2026-04-03T21:06:06.958Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T210258-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T210258-e4d80f44","recordedAt":"2026-04-03T21:02:58.122Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205942-58d64fdc::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T205942-58d64fdc","recordedAt":"2026-04-03T20:59:42.136Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::alpelisib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"ALPELISIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205635-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T205635-a06eb5f4","recordedAt":"2026-04-03T20:56:35.327Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T205348-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T205348-eb82e08b","recordedAt":"2026-04-03T20:53:48.797Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::selumetinib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","NRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::alpelisib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"ALPELISIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","NRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::adagrasib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::dabrafenib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","NRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::encorafenib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::sorafenib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","NRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::tovorafenib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::temsirolimus::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T183033-6160b494::regorafenib::colorectal_cancer","analysisId":"20260403T183033-6160b494","recordedAt":"2026-04-03T18:30:33.442Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS","PIK3CA"],"targets":["BRAF","KRAS","NRAS","PIK3CA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::relatlimab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Relatlimab","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["LAG3"],"confidence":"low","phase":"FDA Approved","mechanism":"Anti-LAG-3 monoclonal antibody; combined with nivolumab (Opdualag) for melanoma, blocks LAG-3 exhaustion pathway","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::durvalumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"DURVALUMAB","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["CD274"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::cemiplimab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"CEMIPLIMAB","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["PDCD1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::avelumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"AVELUMAB","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["CD274"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::nivolumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Nivolumab","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["PDCD1"],"confidence":"low","phase":"FDA Approved","mechanism":"Anti-PD-1 IgG4 monoclonal antibody; restores effector T-cell function by blocking PD-1","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::ipilimumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Ipilimumab","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"Anti-CTLA-4 monoclonal antibody; enhances T-cell activation by blocking CTLA-4 co-inhibitory signaling","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::dabrafenib::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Dabrafenib","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"Selective BRAF V600E/V600K kinase inhibitor; combined with trametinib for BRAF-mutant melanoma","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::atezolizumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"ATEZOLIZUMAB","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["CD274"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::dostarlimab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Dostarlimab","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["PDCD1"],"confidence":"low","phase":"FDA Approved","mechanism":"Anti-PD-1 monoclonal antibody; approved for dMMR/MSI-H cancers including solid tumors","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T182425-71278042::pembrolizumab::metastatic_melanoma_inflamed_tme_checkpoint_immunotherapy_candidate","analysisId":"20260403T182425-71278042","recordedAt":"2026-04-03T18:24:26.013Z","drug":"Pembrolizumab","disease":"metastatic melanoma inflamed TME checkpoint immunotherapy candidate","genes":["CD274","CD8A","CXCL10","CXCL9","HAVCR2","LAG3","PDCD1","TIGIT"],"targets":["PDCD1"],"confidence":"low","phase":"FDA Approved","mechanism":"Anti-PD-1 monoclonal antibody; blocks PD-1/PD-L1 interaction to restore T-cell anti-tumor activity","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::solanezumab::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"SOLANEZUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::gantenerumab::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"GANTENERUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T180156-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T180156-4e355432","recordedAt":"2026-04-03T18:01:56.797Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175900-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T175900-e4d80f44","recordedAt":"2026-04-03T17:59:00.916Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175603-58d64fdc::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T175603-58d64fdc","recordedAt":"2026-04-03T17:56:03.504Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T175301-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T175301-a06eb5f4","recordedAt":"2026-04-03T17:53:01.997Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T174938-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T174938-eb82e08b","recordedAt":"2026-04-03T17:49:38.500Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::aducanumab::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::solanezumab::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"SOLANEZUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::gantenerumab::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"GANTENERUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"Phase 2","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::rivastigmine::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::galantamine::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::donepezil::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::donanemab::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::lecanemab::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161507-7e98c538::nirogacestat::alzheimers_disease","analysisId":"20260403T161507-7e98c538","recordedAt":"2026-04-03T16:15:07.664Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::vemurafenib::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::palbociclib::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::carboplatin::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::sirolimus::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::panitumumab::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::gemcitabine::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::temozolomide::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::sapanisertib::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::cetuximab::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T161200-1ec8507e::paclitaxel::pan-cancer","analysisId":"20260403T161200-1ec8507e","recordedAt":"2026-04-03T16:12:00.099Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160856-58d64fdc::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T160856-58d64fdc","recordedAt":"2026-04-03T16:08:56.320Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160551-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T160551-a06eb5f4","recordedAt":"2026-04-03T16:05:51.771Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T160225-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T160225-eb82e08b","recordedAt":"2026-04-03T16:02:25.578Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T142008-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T142008-4e355432","recordedAt":"2026-04-03T14:20:08.268Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141710-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T141710-e4d80f44","recordedAt":"2026-04-03T14:17:10.991Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141406-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T141406-a8209daf","recordedAt":"2026-04-03T14:14:06.386Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T141107-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T141107-a06eb5f4","recordedAt":"2026-04-03T14:11:08.002Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T140740-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T140740-eb82e08b","recordedAt":"2026-04-03T14:07:40.678Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::azathioprine::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"AZATHIOPRINE","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["IL23R"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::adalimumab::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"ADALIMUMAB","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::chembl_chembl585502::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"CHEMBL:CHEMBL585502","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"Phase 1","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::chembl_chembl1351908::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"CHEMBL:CHEMBL1351908","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"Phase 1","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::inarigivir_soproxil::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"INARIGIVIR SOPROXIL","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"Phase 1","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::cyclosporine::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"CYCLOSPORINE","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::infliximab::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"INFLIXIMAB","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::anhydrous_tacrolimus::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"ANHYDROUS TACROLIMUS","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::mifamurtide::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"MIFAMURTIDE","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["NOD2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123654-319b778d::celecoxib::inflammatory_bowel_disease","analysisId":"20260403T123654-319b778d","recordedAt":"2026-04-03T12:36:54.226Z","drug":"CELECOXIB","disease":"inflammatory bowel disease","genes":["ATG16L1","IL23R","NOD2"],"targets":["IL23R"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123646-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T123646-4e355432","recordedAt":"2026-04-03T12:36:46.807Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123349-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T123349-e4d80f44","recordedAt":"2026-04-03T12:33:49.296Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T123055-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T123055-a8209daf","recordedAt":"2026-04-03T12:30:55.412Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122756-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T122756-a06eb5f4","recordedAt":"2026-04-03T12:27:56.552Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T122436-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T122436-eb82e08b","recordedAt":"2026-04-03T12:24:36.231Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::nirogacestat::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::rivastigmine::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::donanemab::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::galantamine::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::donepezil::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::lecanemab::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T100124-7e98c538::aducanumab::alzheimers_disease","analysisId":"20260403T100124-7e98c538","recordedAt":"2026-04-03T10:01:24.399Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::carboplatin::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::palbociclib::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::sirolimus::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::panitumumab::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::gemcitabine::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::temozolomide::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::sapanisertib::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::cetuximab::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::vemurafenib::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095919-1ec8507e::paclitaxel::pan-cancer","analysisId":"20260403T095919-1ec8507e","recordedAt":"2026-04-03T09:59:19.363Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095558-dc741d2d::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T095558-dc741d2d","recordedAt":"2026-04-03T09:55:58.060Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T095255-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T095255-a06eb5f4","recordedAt":"2026-04-03T09:52:55.689Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::carboplatin::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::talazoparib::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::rucaparib::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::paclitaxel::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::olaparib::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::niraparib::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::gemcitabine::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T094951-58cd6b72::cisplatin::breast_cancer","analysisId":"20260403T094951-58cd6b72","recordedAt":"2026-04-03T09:49:51.901Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::aducanumab::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::rivastigmine::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::galantamine::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::donepezil::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::donanemab::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::lecanemab::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084625-7e98c538::nirogacestat::alzheimers_disease","analysisId":"20260403T084625-7e98c538","recordedAt":"2026-04-03T08:46:25.330Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::paclitaxel::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::palbociclib::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::carboplatin::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::vemurafenib::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::sirolimus::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::panitumumab::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::gemcitabine::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::temozolomide::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::sapanisertib::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084310-1ec8507e::cetuximab::pan-cancer","analysisId":"20260403T084310-1ec8507e","recordedAt":"2026-04-03T08:43:10.811Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T084022-5e73df69::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T084022-5e73df69","recordedAt":"2026-04-03T08:40:22.473Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083719-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260403T083719-a06eb5f4","recordedAt":"2026-04-03T08:37:19.376Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::talazoparib::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::gemcitabine::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::niraparib::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::olaparib::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::paclitaxel::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::rucaparib::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::carboplatin::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T083409-58cd6b72::cisplatin::breast_cancer","analysisId":"20260403T083409-58cd6b72","recordedAt":"2026-04-03T08:34:09.398Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T061113-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T061113-4e355432","recordedAt":"2026-04-03T06:11:13.142Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060846-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T060846-e4d80f44","recordedAt":"2026-04-03T06:08:46.990Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060610-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T060610-a8209daf","recordedAt":"2026-04-03T06:06:10.591Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00593060","NCT00600496","NCT03190174","NCT00375245","NCT00409994"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:58.421Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T060317-900cc271::regorafenib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213570","NCT02116894","NCT02788279","NCT01896856","NCT07137390"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:06:00.136Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T060317-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T20:05:59.710Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::sorafenib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00839111","NCT01376453","NCT00826540","NCT01715441","NCT00703638"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2009-02-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:59.277Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T060317-900cc271::selumetinib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00600496","NCT02188264","NCT01134601","NCT02586987","NCT01333475"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2008-01-25","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:58.847Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T060317-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::adagrasib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060317-900cc271::encorafenib::colorectal_cancer","analysisId":"20260403T060317-900cc271","recordedAt":"2026-04-03T06:03:17.963Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":null,"outcomeAt":null,"completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T060033-58cd6b72::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00206466","NCT00316875","NCT00003042","NCT05256745","NCT01367288"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:57.135Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T060033-58cd6b72::paclitaxel::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT02423603","NCT04251169","NCT03742102","NCT00003042"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:56.711Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T060033-58cd6b72::gemcitabine::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00191269","NCT06519370","NCT03901339","NCT00403130","NCT04247126"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-19","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:56.285Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T060033-58cd6b72::niraparib::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04762901","NCT03945721","NCT04481113","NCT04764084","NCT06535893"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2021-02-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:55.859Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T060033-58cd6b72::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03901339","NCT07299409","NCT06966141","NCT07011654","NCT06240195"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2019-04-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:55.011Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T060033-58cd6b72::rucaparib::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01074970","NCT02711137","NCT03101280","NCT03840200","NCT03911453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2010-02-24","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:54.160Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T060033-58cd6b72::cisplatin::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07413601","NCT00003042","NCT02199418","NCT01143974","NCT03251313"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:57.571Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T060033-58cd6b72::talazoparib::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04550494","NCT04849364","NCT04982848","NCT02286687","NCT03426254"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2020-09-16","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:54.587Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T060033-58cd6b72::olaparib::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05536128","NCT07005583","NCT03641755","NCT03286842","NCT05203445"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2022-09-10","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:55.435Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T060033-58cd6b72::carboplatin::breast_cancer","analysisId":"20260403T060033-58cd6b72","recordedAt":"2026-04-03T06:00:33.967Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT06884254","NCT07413601","NCT05256745","NCT01625429"],"trialFound":true,"trialCompleted":false,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:57.996Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T040737-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T20:05:52.458Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T040737-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06602258","NCT06810960","NCT07505095","NCT06285448","NCT07034222"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2024-09-19","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:51.601Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260403T040737-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02035982","NCT00236431","NCT00304629","NCT02703636","NCT01852110"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2014-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:51.174Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T040737-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT04437511","NCT05026866","NCT05508789","NCT05108922"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:53.734Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260403T040737-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00096473","NCT01955161","NCT02035982","NCT03283059","NCT01276353"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2004-11-10","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:53.308Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T040737-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02035982","NCT04731311","NCT02703636","NCT00506415","NCT01852110"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2014-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:52.883Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T040737-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T040737-4e355432","recordedAt":"2026-04-03T04:07:37.022Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02782975","NCT01397539","NCT02484547","NCT01677572","NCT04241068"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-05-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:52.025Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":0},{"id":"20260403T040408-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T20:05:49.884Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T040408-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:50.748Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T040408-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03989336","NCT06297811","NCT06333314","NCT06607185","NCT02476955"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2019-06-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:50.310Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T040408-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:49.459Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T040408-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T20:05:49.035Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T040408-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03989310","NCT07336953","NCT04004234","NCT04969731","NCT06991491"],"trialFound":true,"trialCompleted":false,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2019-06-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:48.608Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T040408-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04566380","NCT06739395","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2020-09-28","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T20:05:48.175Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T040408-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01473095","NCT03065387"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2011-11-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T20:05:47.747Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T040408-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05693844","NCT04872985","NCT03989336","NCT06297811","NCT03989310"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2023-01-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:51.576Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T040408-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T040408-e4d80f44","recordedAt":"2026-04-03T04:04:08.655Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT03065387","NCT06126276","NCT03238196"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:51.151Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T040050-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05663866","NCT06083857","NCT04965090","NCT05601973","NCT07469488"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-12-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:50.710Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T040050-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04576208","NCT03807778","NCT05863819","NCT05207423","NCT04051827"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2020-10-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:50.286Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T040050-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02838420","NCT06586801","NCT03546894","NCT04708639","NCT05525338"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2016-07-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:47.285Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T040050-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06083857","NCT02864992","NCT06106802","NCT01982955","NCT03940703"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2023-10-16","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:48.561Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T040050-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03546894","NCT01685060","NCT02321501","NCT01828112","NCT03611738"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-06-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:46.851Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T040050-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:30:49.412Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T040050-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03389399","NCT04223596","NCT03546894","NCT05200481","NCT02784158"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-01-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:49.854Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T040050-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00193453","NCT04956640","NCT01178411","NCT04349267","NCT00118183"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-19","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:48.987Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T040050-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637597","NCT02838420","NCT03718117","NCT01639001","NCT03546894"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:48.135Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T040050-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T040050-a8209daf","recordedAt":"2026-04-03T04:00:50.346Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03612154","NCT06586801","NCT04541407","NCT03546894","NCT03439215"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2018-08-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:47.710Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T035729-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:30:44.581Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T035729-900cc271::adagrasib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06026410","NCT05578092","NCT03785249","NCT07318389","NCT04793958"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2023-09-07","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:30:46.418Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260403T035729-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00593060","NCT00600496","NCT03190174","NCT00375245","NCT00409994"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:43.240Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T035729-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:30:45.960Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T035729-900cc271::encorafenib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05639413","NCT05706779","NCT01436656","NCT05743036","NCT06207656"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2022-12-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:45.506Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T035729-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06967155","NCT01750918","NCT03668431","NCT07506109","NCT04294160"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2025-05-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:45.042Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T035729-900cc271::selumetinib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00600496","NCT02188264","NCT01134601","NCT02586987","NCT01333475"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2008-01-25","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:43.701Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T035729-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02788279","NCT02777710","NCT03519295","NCT05845450","NCT04017455"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-06-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:44.127Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T035729-900cc271::regorafenib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213570","NCT02116894","NCT02788279","NCT01896856","NCT07137390"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:42.309Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T035729-900cc271::sorafenib::colorectal_cancer","analysisId":"20260403T035729-900cc271","recordedAt":"2026-04-03T03:57:29.384Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00839111","NCT01376453","NCT00826540","NCT01715441","NCT00703638"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2009-02-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:42.764Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T035411-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT02423603","NCT04251169","NCT03742102","NCT00003042"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:40.457Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T035411-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04550494","NCT04849364","NCT04982848","NCT02286687","NCT03426254"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2020-09-16","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:30:41.846Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T035411-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00191269","NCT06519370","NCT03901339","NCT00403130","NCT04247126"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-19","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:41.377Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T035411-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01074970","NCT02711137","NCT03101280","NCT03840200","NCT03911453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2010-02-24","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:39.996Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T035411-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03901339","NCT07299409","NCT06966141","NCT07011654","NCT06240195"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2019-04-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:39.040Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T035411-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05536128","NCT07005583","NCT03641755","NCT03286842","NCT05203445"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2022-09-10","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:38.580Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T035411-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07413601","NCT00003042","NCT02199418","NCT01143974","NCT03251313"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:44.440Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T035411-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT06884254","NCT07413601","NCT05256745","NCT01625429"],"trialFound":true,"trialCompleted":false,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:24:43.980Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T035411-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04762901","NCT03945721","NCT04481113","NCT04764084","NCT06535893"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2021-02-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:39.514Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T035411-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T035411-eb82e08b","recordedAt":"2026-04-03T03:54:11.786Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00206466","NCT00316875","NCT00003042","NCT05256745","NCT01367288"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:30:40.919Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T015746-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02782975","NCT01397539","NCT02484547","NCT01677572","NCT04241068"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-05-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:41.680Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":0},{"id":"20260403T015746-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06602258","NCT06810960","NCT07505095","NCT06285448","NCT07034222"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2024-09-19","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:24:43.060Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260403T015746-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:24:43.525Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T015746-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02035982","NCT04731311","NCT02703636","NCT00506415","NCT01852110"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2014-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:41.225Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T015746-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00096473","NCT01955161","NCT02035982","NCT03283059","NCT01276353"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2004-11-10","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:42.138Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T015746-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT04437511","NCT05026866","NCT05508789","NCT05108922"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:42.600Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260403T015746-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T015746-4e355432","recordedAt":"2026-04-03T01:57:46.804Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02035982","NCT00236431","NCT00304629","NCT02703636","NCT01852110"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2014-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:40.763Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T015502-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03989336","NCT06297811","NCT06333314","NCT06607185","NCT02476955"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2019-06-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:37.976Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:24:38.882Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T015502-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03989310","NCT07336953","NCT04004234","NCT04969731","NCT06991491"],"trialFound":true,"trialCompleted":false,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2019-06-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:24:39.337Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04566380","NCT06739395","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2020-09-28","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T18:24:39.806Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:24:40.250Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T015502-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:36.147Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:24:38.426Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T015502-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05693844","NCT04872985","NCT03989336","NCT06297811","NCT03989310"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2023-01-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:36.605Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT03065387","NCT06126276","NCT03238196"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:37.064Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T015502-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T015502-e4d80f44","recordedAt":"2026-04-03T01:55:02.698Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01473095","NCT03065387"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2011-11-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:37.518Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T015202-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00193453","NCT04956640","NCT01178411","NCT04349267","NCT00118183"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-19","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:33.380Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T015202-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05663866","NCT06083857","NCT04965090","NCT05601973","NCT07469488"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-12-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:31.516Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T015202-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03546894","NCT01685060","NCT02321501","NCT01828112","NCT03611738"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-06-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:34.763Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T015202-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637597","NCT02838420","NCT03718117","NCT01639001","NCT03546894"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:35.690Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T015202-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T18:24:34.294Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T015202-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06083857","NCT02864992","NCT06106802","NCT01982955","NCT03940703"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2023-10-16","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:32.914Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T015202-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03389399","NCT04223596","NCT03546894","NCT05200481","NCT02784158"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-01-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:32.453Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T015202-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04576208","NCT03807778","NCT05863819","NCT05207423","NCT04051827"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2020-10-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:31.985Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T015202-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03612154","NCT06586801","NCT04541407","NCT03546894","NCT03439215"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2018-08-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:35.221Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T015202-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T015202-a8209daf","recordedAt":"2026-04-03T01:52:02.859Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02838420","NCT06586801","NCT03546894","NCT04708639","NCT05525338"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2016-07-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:33.840Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T014906-900cc271::adagrasib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06026410","NCT05578092","NCT03785249","NCT07318389","NCT04793958"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2023-09-07","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T16:23:15.378Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260403T014906-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02788279","NCT02777710","NCT03519295","NCT05845450","NCT04017455"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-06-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T18:24:31.054Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T014906-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06967155","NCT01750918","NCT03668431","NCT07506109","NCT04294160"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2025-05-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:11.704Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T014906-900cc271::selumetinib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00600496","NCT02188264","NCT01134601","NCT02586987","NCT01333475"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2008-01-25","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:14.009Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T014906-900cc271::sorafenib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00839111","NCT01376453","NCT00826540","NCT01715441","NCT00703638"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2009-02-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:12.634Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T014906-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T16:23:13.092Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014906-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00593060","NCT00600496","NCT03190174","NCT00375245","NCT00409994"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:13.546Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T014906-900cc271::regorafenib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213570","NCT02116894","NCT02788279","NCT01896856","NCT07137390"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:14.463Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T014906-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:14.915Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014906-900cc271::encorafenib::colorectal_cancer","analysisId":"20260403T014906-900cc271","recordedAt":"2026-04-03T01:49:06.760Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05639413","NCT05706779","NCT01436656","NCT05743036","NCT06207656"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2022-12-06","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:12.179Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T014612-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01074970","NCT02711137","NCT03101280","NCT03840200","NCT03911453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2010-02-24","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:09.840Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T014612-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04550494","NCT04849364","NCT04982848","NCT02286687","NCT03426254"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2020-09-16","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T16:23:08.916Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T014612-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT06884254","NCT07413601","NCT05256745","NCT01625429"],"trialFound":true,"trialCompleted":false,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T16:23:09.376Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T014612-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00206466","NCT00316875","NCT00003042","NCT05256745","NCT01367288"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:06.983Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T014612-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05536128","NCT07005583","NCT03641755","NCT03286842","NCT05203445"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2022-09-10","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:10.767Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":4},{"id":"20260403T014612-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07413601","NCT00003042","NCT02199418","NCT01143974","NCT03251313"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:07.466Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T014612-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03901339","NCT07299409","NCT06966141","NCT07011654","NCT06240195"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2019-04-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:07.962Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T014612-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04762901","NCT03945721","NCT04481113","NCT04764084","NCT06535893"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2021-02-21","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:08.458Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T014612-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00191269","NCT06519370","NCT03901339","NCT00403130","NCT04247126"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-19","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:11.238Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T014612-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T014612-eb82e08b","recordedAt":"2026-04-03T01:46:12.928Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03872505","NCT02423603","NCT04251169","NCT03742102","NCT00003042"],"trialFound":true,"trialCompleted":true,"trialStatus":"WITHDRAWN","trialFirstPostedDate":"2019-03-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:10.298Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T014549-22406a1e::tofacitinib::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"tofacitinib","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["LRRK2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:05.384Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::ruxolitinib::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"ruxolitinib","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["LRRK2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:04.414Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::mycophenolate::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"MYCOPHENOLATE","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["SNCA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:03.961Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::vandetanib::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"VANDETANIB","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["LRRK2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:03.495Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::tretinoin::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"tretinoin","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["SNCA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:05.850Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::doxorubicin_hydrochloride::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["SNCA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:06.506Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::gentian_violet_cation::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"GENTIAN VIOLET CATION","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["SNCA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:04.895Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::entrectinib::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"ENTRECTINIB","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["LRRK2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:02.567Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::ketoconazole::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"KETOCONAZOLE","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["SNCA"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:03.022Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T014549-22406a1e::palbociclib::parkinson's_disease","analysisId":"20260403T014549-22406a1e","recordedAt":"2026-04-03T01:45:49.401Z","drug":"PALBOCICLIB","disease":"Parkinson's disease","genes":["LRRK2","PARK7","SNCA"],"targets":["LRRK2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T16:23:02.100Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003914-4e355432::aducanumab::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01677572","NCT01397539","NCT04241068","NCT05310071","NCT03639987"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2012-09-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:18.919Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":0},{"id":"20260403T003914-4e355432::lecanemab::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213700","NCT07034222","NCT06741553","NCT06602258","NCT06322667"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:18.458Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260403T003914-4e355432::donepezil::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00884507","NCT04731311","NCT01137526","NCT03283059","NCT00428090"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2009-04-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:17.524Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T003914-4e355432::donanemab::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT05738486","NCT05026866","NCT06911944","NCT03367403"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:17.999Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260403T003914-4e355432::galantamine::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00523666","NCT00679627","NCT00750529","NCT07208344","NCT01734395"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2007-08-31","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:17.063Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T003914-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T13:22:19.365Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003914-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260403T003914-4e355432","recordedAt":"2026-04-03T00:39:14.641Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02035982","NCT04731311","NCT02703636","NCT00506415","NCT01852110"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2014-01-14","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T16:23:01.650Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T003634-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T13:22:13.834Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003634-e4d80f44::carboplatin::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02476955","NCT03989336","NCT06297811","NCT06333314","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2015-06-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:15.661Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T003634-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT05693844","NCT02476955","NCT03989336","NCT04004234"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:15.205Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T003634-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T13:22:14.742Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003634-e4d80f44::cetuximab::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:14.292Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T003634-e4d80f44::temozolomide::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT04566380","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:16.125Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T003634-e4d80f44::palbociclib::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT06739395","NCT03238196","NCT06126276"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:12.447Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T003634-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT04004234","NCT07336953","NCT06333314","NCT04969731"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:12.908Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260403T003634-e4d80f44::sirolimus::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT01473095"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:13.384Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T003634-e4d80f44::panitumumab::pan-cancer","analysisId":"20260403T003634-e4d80f44","recordedAt":"2026-04-03T00:36:34.485Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:16.586Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003348-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT04115410","NCT03546894","NCT02513667","NCT02422589"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:11.046Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260403T003348-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04535557","NCT02716116","NCT04576208","NCT05207423","NCT05241873"],"trialFound":true,"trialCompleted":true,"trialStatus":"APPROVED_FOR_MARKETING","trialFirstPostedDate":"2020-09-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:10.118Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260403T003348-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T13:22:09.180Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003348-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02013219","NCT03737994","NCT06339554","NCT06624059","NCT04115410"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-12-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:08.239Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T003348-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04487080","NCT07174388","NCT05498428","NCT05299125","NCT06532032"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2020-07-27","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:08.728Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260403T003348-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03940703","NCT04739358","NCT01982955","NCT03531762","NCT06083857"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2019-05-07","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:11.985Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T003348-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT07083687","NCT03612154","NCT07491497","NCT03727477"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:11.511Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T003348-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00034541","NCT02857270","NCT00216203","NCT03319459","NCT06179160"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2002-05-01","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:10.580Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T003348-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT01121575","NCT04115410","NCT04439253","NCT05204628"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:09.650Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T003348-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260403T003348-a8209daf","recordedAt":"2026-04-03T00:33:48.296Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05100069","NCT03737994","NCT03546894","NCT03410108","NCT04005144"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-10-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:07.763Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T003043-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:00:01.695Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003043-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:00:01.238Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260403T003043-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:05.901Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260403T003043-900cc271::encorafenib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:06.373Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260403T003043-900cc271::selumetinib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:59.414Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260403T003043-900cc271::adagrasib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:22:07.298Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260403T003043-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05411133","NCT02912559","NCT02876224","NCT04432597","NCT05733611"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2022-06-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T13:22:06.835Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260403T003043-900cc271::regorafenib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T13:00:00.779Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260403T003043-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T13:00:00.317Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260403T003043-900cc271::sorafenib::colorectal_cancer","analysisId":"20260403T003043-900cc271","recordedAt":"2026-04-03T00:30:43.651Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:59.864Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260403T002800-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:58.024Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260403T002800-eb82e08b::carboplatin::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:58.955Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T002800-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:57.565Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260403T002800-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:57.109Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T002800-eb82e08b::niraparib::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:56.651Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260403T002800-eb82e08b::olaparib::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:56.193Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T002800-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:55.273Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260403T002800-eb82e08b::cisplatin::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:58.496Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260403T002800-eb82e08b::rucaparib::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:55.734Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260403T002800-eb82e08b::talazoparib::breast_cancer","analysisId":"20260403T002800-eb82e08b","recordedAt":"2026-04-03T00:28:00.648Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:54.818Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T230715-4e355432::lecanemab::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213700","NCT07034222","NCT06741553","NCT06602258","NCT06322667"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:53.438Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T230715-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T12:59:52.522Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T230715-4e355432::donanemab::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT05738486","NCT05026866","NCT06911944","NCT03367403"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:52.064Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260402T230715-4e355432::donepezil::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00884507","NCT04731311","NCT01137526","NCT03283059","NCT00428090"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2009-04-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:51.595Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T230715-4e355432::aducanumab::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01677572","NCT01397539","NCT04241068","NCT05310071","NCT03639987"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2012-09-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:52.981Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":0},{"id":"20260402T230715-4e355432::galantamine::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00523666","NCT00679627","NCT00750529","NCT07208344","NCT01734395"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2007-08-31","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:54.358Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T230715-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260402T230715-4e355432","recordedAt":"2026-04-02T23:07:15.579Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04731311","NCT01047579","NCT07208344","NCT01183806","NCT05564169"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2021-01-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:53.899Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T230440-e4d80f44::sirolimus::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT01473095"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:48.390Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T230440-e4d80f44::panitumumab::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:49.759Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T230440-e4d80f44::palbociclib::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT06739395","NCT03238196","NCT06126276"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:10.784Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T230440-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT05693844","NCT02476955","NCT03989336","NCT04004234"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:11.248Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T230440-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T12:37:11.710Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T230440-e4d80f44::temozolomide::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT04566380","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:51.136Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T230440-e4d80f44::carboplatin::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02476955","NCT03989336","NCT06297811","NCT06333314","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2015-06-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:50.674Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T230440-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T12:59:50.219Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T230440-e4d80f44::cetuximab::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:59:49.306Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T230440-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260402T230440-e4d80f44","recordedAt":"2026-04-02T23:04:40.321Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT04004234","NCT07336953","NCT06333314","NCT04969731"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:59:48.849Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T230150-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02013219","NCT03737994","NCT06339554","NCT06624059","NCT04115410"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-12-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:06.500Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T230150-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT04115410","NCT03546894","NCT02513667","NCT02422589"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:06.027Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T230150-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05100069","NCT03737994","NCT03546894","NCT03410108","NCT04005144"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-10-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:07.451Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T230150-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT07083687","NCT03612154","NCT07491497","NCT03727477"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:06.973Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T230150-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT01121575","NCT04115410","NCT04439253","NCT05204628"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:07.922Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T230150-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04487080","NCT07174388","NCT05498428","NCT05299125","NCT06532032"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2020-07-27","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:37:09.852Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T230150-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03940703","NCT04739358","NCT01982955","NCT03531762","NCT06083857"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2019-05-07","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:08.402Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T230150-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04535557","NCT02716116","NCT04576208","NCT05207423","NCT05241873"],"trialFound":true,"trialCompleted":true,"trialStatus":"APPROVED_FOR_MARKETING","trialFirstPostedDate":"2020-09-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:09.378Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T230150-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T12:37:08.912Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T230150-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260402T230150-a8209daf","recordedAt":"2026-04-02T23:01:50.378Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00034541","NCT02857270","NCT00216203","NCT03319459","NCT06179160"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2002-05-01","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:10.321Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T225904-a06eb5f4::tovorafenib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:37:05.085Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T225904-a06eb5f4::encorafenib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:04.627Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260402T225904-a06eb5f4::dabrafenib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:04.106Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T225904-a06eb5f4::atezolizumab::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05411133","NCT02912559","NCT02876224","NCT04432597","NCT05733611"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2022-06-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:03.119Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T225904-a06eb5f4::adagrasib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:37:02.187Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T225904-a06eb5f4::regorafenib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:37:03.573Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260402T225904-a06eb5f4::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T12:37:01.161Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T225904-a06eb5f4::sorafenib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:05.552Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T225904-a06eb5f4::selumetinib::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:02.657Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T225904-a06eb5f4::temsirolimus::colorectal_cancer","analysisId":"20260402T225904-a06eb5f4","recordedAt":"2026-04-02T22:59:04.846Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:01.617Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260402T225556-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:00.252Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T225556-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:36:58.846Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T225556-eb82e08b::olaparib::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:36:59.796Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T225556-eb82e08b::niraparib::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T12:36:58.380Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T225556-eb82e08b::rucaparib::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:36:57.916Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T225556-eb82e08b::cisplatin::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:07.635Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T225556-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:08.093Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T225556-eb82e08b::carboplatin::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:46:07.174Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T225556-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:36:59.318Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T225556-eb82e08b::talazoparib::breast_cancer","analysisId":"20260402T225556-eb82e08b","recordedAt":"2026-04-02T22:55:56.026Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T12:37:00.712Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T215403-4e355432::lecanemab::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213700","NCT07034222","NCT06741553","NCT06602258","NCT06322667"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:46:05.307Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T215403-4e355432::donepezil::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00884507","NCT04731311","NCT01137526","NCT03283059","NCT00428090"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2009-04-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:06.222Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T215403-4e355432::galantamine::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00523666","NCT00679627","NCT00750529","NCT07208344","NCT01734395"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2007-08-31","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:03.930Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T215403-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T01:46:04.847Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T215403-4e355432::aducanumab::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01677572","NCT01397539","NCT04241068","NCT05310071","NCT03639987"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2012-09-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:05.769Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":0},{"id":"20260402T215403-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04731311","NCT01047579","NCT07208344","NCT01183806","NCT05564169"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2021-01-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:04.392Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T215403-4e355432::donanemab::alzheimers_disease","analysisId":"20260402T215403-4e355432","recordedAt":"2026-04-02T21:54:03.074Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT05738486","NCT05026866","NCT06911944","NCT03367403"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:06.710Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260402T215126-e4d80f44::palbociclib::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT06739395","NCT03238196","NCT06126276"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:00.273Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T215126-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT05693844","NCT02476955","NCT03989336","NCT04004234"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:59.816Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T215126-e4d80f44::carboplatin::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02476955","NCT03989336","NCT06297811","NCT06333314","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2015-06-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:59.361Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T215126-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT04004234","NCT07336953","NCT06333314","NCT04969731"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:46:01.663Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T215126-e4d80f44::panitumumab::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:46:01.180Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T215126-e4d80f44::sirolimus::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT01473095"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:00.728Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T215126-e4d80f44::cetuximab::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:46:03.032Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T215126-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T01:46:02.577Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T215126-e4d80f44::temozolomide::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT04566380","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:46:02.130Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T215126-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260402T215126-e4d80f44","recordedAt":"2026-04-02T21:51:26.049Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T01:46:03.477Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214837-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04487080","NCT07174388","NCT05498428","NCT05299125","NCT06532032"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2020-07-27","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-03T01:45:57.514Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T214837-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT01121575","NCT04115410","NCT04439253","NCT05204628"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:57.059Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T214837-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05100069","NCT03737994","NCT03546894","NCT03410108","NCT04005144"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-10-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:56.125Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T214837-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00034541","NCT02857270","NCT00216203","NCT03319459","NCT06179160"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2002-05-01","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:55.663Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T214837-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02013219","NCT03737994","NCT06339554","NCT06624059","NCT04115410"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-12-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:54.707Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T214837-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT04115410","NCT03546894","NCT02513667","NCT02422589"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:55.202Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T214837-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04535557","NCT02716116","NCT04576208","NCT05207423","NCT05241873"],"trialFound":true,"trialCompleted":true,"trialStatus":"APPROVED_FOR_MARKETING","trialFirstPostedDate":"2020-09-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:58.879Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T214837-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT07083687","NCT03612154","NCT07491497","NCT03727477"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:58.423Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T214837-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-03T01:45:57.964Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214837-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260402T214837-a8209daf","recordedAt":"2026-04-02T21:48:37.121Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03940703","NCT04739358","NCT01982955","NCT03531762","NCT06083857"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2019-05-07","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-03T01:45:56.598Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T214541-900cc271::adagrasib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:48:25.939Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T214541-900cc271::regorafenib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:48:22.474Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260402T214541-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05411133","NCT02912559","NCT02876224","NCT04432597","NCT05733611"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2022-06-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:26.410Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T214541-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:48:22.918Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214541-900cc271::selumetinib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:23.784Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T214541-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:24.212Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260402T214541-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:48:24.649Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214541-900cc271::encorafenib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:25.080Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260402T214541-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:25.507Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T214541-900cc271::sorafenib::colorectal_cancer","analysisId":"20260402T214541-900cc271","recordedAt":"2026-04-02T21:45:41.694Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:48:23.343Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T214436-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:48.092Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214436-900cc271::regorafenib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:45.771Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260402T214436-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:49.022Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T214436-900cc271::encorafenib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:48.556Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260402T214436-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:44:46.710Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T214436-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:47.635Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260402T214436-900cc271::selumetinib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:46.234Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T214436-900cc271::sorafenib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:47.174Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T214436-900cc271::sotorasib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"SOTORASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06645236","NCT07318389","NCT07124884","NCT05845450","NCT06252649"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-10-16","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:49.938Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T214436-900cc271::adagrasib::colorectal_cancer","analysisId":"20260402T214436-900cc271","recordedAt":"2026-04-02T21:44:36.894Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:49.474Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T214254-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:42.534Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T214254-eb82e08b::carboplatin::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:41.108Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T214254-eb82e08b::niraparib::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:42.999Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T214254-eb82e08b::rucaparib::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:44.387Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T214254-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:44.851Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T214254-eb82e08b::talazoparib::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:45.315Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T214254-eb82e08b::olaparib::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:44:43.463Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T214254-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:42.073Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T214254-eb82e08b::cisplatin::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:41.582Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T214254-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260402T214254-eb82e08b","recordedAt":"2026-04-02T21:42:54.236Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:44:43.923Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T213256-d9940156::pioglitazone_hydrochloride::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"PIOGLITAZONE HYDROCHLORIDE","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:02.582Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::procarbazine_hydrochloride::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"PROCARBAZINE HYDROCHLORIDE","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:04.884Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::melatonin::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"MELATONIN","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:00.843Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::aspirin::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"ASPIRIN","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:02.116Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::genistein::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"GENISTEIN","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:05.347Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::nifedipine::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"NIFEDIPINE","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP","MAPT"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:03.042Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::lithium::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"LITHIUM","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:04.423Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::masoprocol::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"MASOPROCOL","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP","MAPT"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:03.514Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::sorbitol::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"SORBITOL","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:03.961Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T213256-d9940156::interleukin_11::neurodegeneration_biomarker_panel","analysisId":"20260402T213256-d9940156","recordedAt":"2026-04-02T21:32:56.330Z","drug":"INTERLEUKIN-11","disease":"neurodegeneration biomarker panel","genes":["GFAP","MAPT","NEFL","S100B"],"targets":["GFAP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:33:01.294Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T201006-4e355432::lecanemab::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213700","NCT07034222","NCT06741553","NCT06602258","NCT06322667"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:26:36.522Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T201006-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04731311","NCT01047579","NCT07208344","NCT01183806","NCT05564169"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2021-01-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:38.215Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T201006-4e355432::galantamine::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00523666","NCT00679627","NCT00750529","NCT07208344","NCT01734395"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2007-08-31","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:37.792Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T201006-4e355432::donepezil::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00884507","NCT04731311","NCT01137526","NCT03283059","NCT00428090"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2009-04-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:37.369Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T201006-4e355432::donanemab::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT05738486","NCT05026866","NCT06911944","NCT03367403"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:36.945Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260402T201006-4e355432::aducanumab::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01677572","NCT01397539","NCT04241068","NCT05310071","NCT03639987"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2012-09-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:36.099Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":0},{"id":"20260402T201006-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260402T201006-4e355432","recordedAt":"2026-04-02T20:10:06.936Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:26:35.676Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200723-e4d80f44::paclitaxel::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT05693844","NCT02476955","NCT03989336","NCT04004234"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:18.860Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T200723-e4d80f44::cetuximab::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:19.735Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T200723-e4d80f44::sapanisertib::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T21:26:32.713Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200723-e4d80f44::temozolomide::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT04566380","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:26:33.136Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T200723-e4d80f44::gemcitabine::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT04004234","NCT07336953","NCT06333314","NCT04969731"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:26:33.558Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T200723-e4d80f44::sirolimus::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT01473095"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:34.407Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T200723-e4d80f44::carboplatin::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02476955","NCT03989336","NCT06297811","NCT06333314","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2015-06-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:34.829Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T200723-e4d80f44::palbociclib::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT06739395","NCT03238196","NCT06126276"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T21:26:35.252Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T200723-e4d80f44::panitumumab::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T21:26:33.981Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200723-e4d80f44::vemurafenib::pan-cancer","analysisId":"20260402T200723-e4d80f44","recordedAt":"2026-04-02T20:07:23.607Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:29:19.311Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200426-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04487080","NCT07174388","NCT05498428","NCT05299125","NCT06532032"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2020-07-27","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:14.241Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T200426-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00034541","NCT02857270","NCT00216203","NCT03319459","NCT06179160"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2002-05-01","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:18.436Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T200426-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT01121575","NCT04115410","NCT04439253","NCT05204628"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:16.114Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T200426-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04535557","NCT02716116","NCT04576208","NCT05207423","NCT05241873"],"trialFound":true,"trialCompleted":true,"trialStatus":"APPROVED_FOR_MARKETING","trialFirstPostedDate":"2020-09-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:14.702Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T200426-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT04115410","NCT03546894","NCT02513667","NCT02422589"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:17.980Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T200426-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02013219","NCT03737994","NCT06339554","NCT06624059","NCT04115410"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-12-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:17.515Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T200426-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT07083687","NCT03612154","NCT07491497","NCT03727477"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:17.048Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T200426-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05100069","NCT03737994","NCT03546894","NCT03410108","NCT04005144"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-10-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:16.584Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T200426-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03940703","NCT04739358","NCT01982955","NCT03531762","NCT06083857"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2019-05-07","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:15.633Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T200426-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260402T200426-a8209daf","recordedAt":"2026-04-02T20:04:26.852Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:29:15.159Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200105-900cc271::regorafenib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:09.593Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260402T200105-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:12.854Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T200105-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:11.445Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260402T200105-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:11.896Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200105-900cc271::encorafenib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:12.383Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260402T200105-900cc271::adagrasib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:13.317Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T200105-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05411133","NCT02912559","NCT02876224","NCT04432597","NCT05733611"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2022-06-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:13.780Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T200105-900cc271::selumetinib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:10.977Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T200105-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:29:10.057Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T200105-900cc271::sorafenib::colorectal_cancer","analysisId":"20260402T200105-900cc271","recordedAt":"2026-04-02T20:01:06.015Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:10.515Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T195811-eb82e08b::carboplatin::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:15.429Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T195811-eb82e08b::talazoparib::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:09.122Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T195811-eb82e08b::cisplatin::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:15.006Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195811-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:15.853Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195811-eb82e08b::niraparib::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:06.999Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T195811-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:08.693Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T195811-eb82e08b::rucaparib::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:08.270Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T195811-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:07.847Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T195811-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:29:06.573Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T195811-eb82e08b::olaparib::breast_cancer","analysisId":"20260402T195811-eb82e08b","recordedAt":"2026-04-02T19:58:11.890Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:29:07.424Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195351-eb82e08b::gemcitabine::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:13.146Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195351-eb82e08b::carboplatin::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:14.557Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T195351-eb82e08b::cisplatin::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:14.093Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195351-eb82e08b::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:13.614Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T195351-eb82e08b::olaparib::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:10.283Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T195351-eb82e08b::rucaparib::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:11.706Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T195351-eb82e08b::niraparib::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:12.660Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T195351-eb82e08b::paclitaxel::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:12.167Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T195351-eb82e08b::sacituzumab_govitecan::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:11.226Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T195351-eb82e08b::talazoparib::breast_cancer","analysisId":"20260402T195351-eb82e08b","recordedAt":"2026-04-02T19:53:51.697Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:10.757Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T194127-4e355432::galantamine::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"GALANTAMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00523666","NCT00679627","NCT00750529","NCT07208344","NCT01734395"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2007-08-31","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:08.851Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T194127-4e355432::donepezil::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"DONEPEZIL","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00884507","NCT04731311","NCT01137526","NCT03283059","NCT00428090"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2009-04-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:08.368Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T194127-4e355432::rivastigmine::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"RIVASTIGMINE","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04731311","NCT01047579","NCT07208344","NCT01183806","NCT05564169"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2021-01-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:07.411Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T194127-4e355432::lecanemab::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"LECANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APOE","APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07213700","NCT07034222","NCT06741553","NCT06602258","NCT06322667"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-10-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:07.881Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T194127-4e355432::donanemab::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"DONANEMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04640077","NCT05738486","NCT05026866","NCT06911944","NCT03367403"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2020-11-23","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:06.485Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":3},{"id":"20260402T194127-4e355432::aducanumab::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"ADUCANUMAB","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01677572","NCT01397539","NCT04241068","NCT05310071","NCT03639987"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2012-09-03","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:09.324Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":0},{"id":"20260402T194127-4e355432::nirogacestat::alzheimers_disease","analysisId":"20260402T194127-4e355432","recordedAt":"2026-04-02T19:41:27.213Z","drug":"NIROGACESTAT","disease":"alzheimers disease","genes":["APOE","APP","PSEN1"],"targets":["APP","PSEN1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:23:06.942Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193855-1ec8507e::palbociclib::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"PALBOCICLIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT06739395","NCT03238196","NCT06126276"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:04.616Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T193855-1ec8507e::temozolomide::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"TEMOZOLOMIDE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06739395","NCT04566380","NCT03899155"],"trialFound":true,"trialCompleted":false,"trialStatus":"RECRUITING","trialFirstPostedDate":"2024-12-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:05.535Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T193855-1ec8507e::paclitaxel::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"PACLITAXEL","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT05693844","NCT02476955","NCT03989336","NCT04004234"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:06.006Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T193855-1ec8507e::panitumumab::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"PANITUMUMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05084859"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2021-10-20","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:05.070Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193855-1ec8507e::sapanisertib::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"SAPANISERTIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:23:04.147Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193855-1ec8507e::sirolimus::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"SIROLIMUS","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03065387","NCT01473095"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2017-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:03.696Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T193855-1ec8507e::gemcitabine::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"GEMCITABINE","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05585320","NCT04004234","NCT07336953","NCT06333314","NCT04969731"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2022-10-18","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T20:23:03.237Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T193855-1ec8507e::vemurafenib::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"VEMURAFENIB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T20:23:02.764Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193855-1ec8507e::carboplatin::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"CARBOPLATIN","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02476955","NCT03989336","NCT06297811","NCT06333314","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"TERMINATED","trialFirstPostedDate":"2015-06-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:02.307Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T193855-1ec8507e::cetuximab::pan-cancer","analysisId":"20260402T193855-1ec8507e","recordedAt":"2026-04-02T19:38:55.142Z","drug":"CETUXIMAB","disease":"pan-cancer","genes":["CDKN2A","MDM2","TP53"],"targets":["CDKN2A","TP53"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01816984","NCT07209111","NCT06585488","NCT06607185"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-03-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T20:23:01.840Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T193555-a8209daf::alectinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"ALECTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02013219","NCT03737994","NCT06339554","NCT06624059","NCT04115410"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2013-12-17","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:35.024Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T193555-a8209daf::cetuximab::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"CETUXIMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00034541","NCT02857270","NCT00216203","NCT03319459","NCT06179160"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2002-05-01","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:39.244Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T193555-a8209daf::ceritinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"CERITINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT04115410","NCT03546894","NCT02513667","NCT02422589"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:38.787Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":1},{"id":"20260402T193555-a8209daf::lorlatinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"LORLATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT07083687","NCT03612154","NCT07491497","NCT03727477"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:38.322Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T193555-a8209daf::brigatinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"BRIGATINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05100069","NCT03737994","NCT03546894","NCT03410108","NCT04005144"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-10-29","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:37.846Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T193555-a8209daf::crizotinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"CRIZOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03737994","NCT01121575","NCT04115410","NCT04439253","NCT05204628"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2018-11-13","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:37.379Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T193555-a8209daf::tepotinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"TEPOTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["ALK","EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03940703","NCT04739358","NCT01982955","NCT03531762","NCT06083857"],"trialFound":true,"trialCompleted":true,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2019-05-07","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:36.906Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T193555-a8209daf::mobocertinib_succinate::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"MOBOCERTINIB SUCCINATE","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T19:50:36.435Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193555-a8209daf::mobocertinib::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"MOBOCERTINIB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04535557","NCT02716116","NCT04576208","NCT05207423","NCT05241873"],"trialFound":true,"trialCompleted":true,"trialStatus":"APPROVED_FOR_MARKETING","trialFirstPostedDate":"2020-09-02","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:35.978Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":1},{"id":"20260402T193555-a8209daf::amivantamab::non-small_cell_lung_cancer","analysisId":"20260402T193555-a8209daf","recordedAt":"2026-04-02T19:35:55.879Z","drug":"AMIVANTAMAB","disease":"non-small cell lung cancer","genes":["ALK","EGFR","MET"],"targets":["EGFR","MET"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04487080","NCT07174388","NCT05498428","NCT05299125","NCT06532032"],"trialFound":true,"trialCompleted":false,"trialStatus":"ACTIVE_NOT_RECRUITING","trialFirstPostedDate":"2020-07-27","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:35.499Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":5},{"id":"20260402T193251-900cc271::regorafenib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"REGORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT06006923","NCT05582031","NCT06911684","NCT05023720","NCT03475953"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2023-08-23","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:30.811Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":1},{"id":"20260402T193251-900cc271::dabrafenib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"DABRAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07440290","NCT03668431","NCT01750918","NCT06967155","NCT04439292"],"trialFound":true,"trialCompleted":true,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2026-02-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:34.074Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":3},{"id":"20260402T193251-900cc271::atezolizumab::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"ATEZOLIZUMAB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":[],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05411133","NCT02912559","NCT02876224","NCT04432597","NCT05733611"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2022-06-09","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:34.559Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":2,"activeTrialCount":2},{"id":"20260402T193251-900cc271::encorafenib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"ENCORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02857270","NCT05706779","NCT02928224","NCT05004350","NCT01719380"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2016-08-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:33.609Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":1},{"id":"20260402T193251-900cc271::tovorafenib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"TOVORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07121829","NCT04985604"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2025-08-14","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:33.124Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193251-900cc271::temsirolimus::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"TEMSIROLIMUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT01637194","NCT03190174","NCT06301386","NCT04230499","NCT00375245"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2012-07-11","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:32.666Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":2},{"id":"20260402T193251-900cc271::adagrasib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"ADAGRASIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05578092","NCT06026410","NCT04793958","NCT07318389","NCT05722327"],"trialFound":true,"trialCompleted":false,"trialStatus":"TERMINATED","trialFirstPostedDate":"2022-10-13","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:30.340Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T193251-900cc271::dasatinib_anhydrous::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"DASATINIB ANHYDROUS","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":[],"trialFound":false,"trialCompleted":false,"trialStatus":null,"trialFirstPostedDate":null,"isProspective":false,"outcomeVerdict":"insufficient_data","outcomeAt":"2026-04-02T19:50:31.275Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":0},{"id":"20260402T193251-900cc271::sorafenib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"SORAFENIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00780169","NCT00989469","NCT01471353","NCT01507740","NCT01376453"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2008-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:31.740Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T193251-900cc271::selumetinib::colorectal_cancer","analysisId":"20260402T193251-900cc271","recordedAt":"2026-04-02T19:32:51.840Z","drug":"SELUMETINIB","disease":"colorectal cancer","genes":["BRAF","KRAS","NRAS"],"targets":["BRAF","KRAS","NRAS"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02586987","NCT01217450","NCT01116271","NCT01160926","NCT01287130"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-10-27","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:32.203Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":4,"activeTrialCount":0},{"id":"20260402T192958-58cd6b72::carboplatin::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"CARBOPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07191405","NCT03424005","NCT00025688","NCT00431704","NCT05867251"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-24","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:27.033Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T192958-58cd6b72::doxorubicin_hydrochloride::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"DOXORUBICIN HYDROCHLORIDE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT00196872","NCT04753177","NCT04654195","NCT00798070","NCT05296746"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2005-09-20","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:26.047Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T192958-58cd6b72::cisplatin::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"CISPLATIN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT07191405","NCT02595905","NCT04491942","NCT02185352"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:25.547Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":1,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T192958-58cd6b72::rucaparib::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"RUCAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT02505048","NCT04171700","NCT01074970","NCT03101280","NCT02711137"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2015-07-22","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:28.932Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":0},{"id":"20260402T192958-58cd6b72::paclitaxel::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"PACLITAXEL","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT03705429","NCT02060253","NCT00196872","NCT04753177","NCT02788981"],"trialFound":true,"trialCompleted":true,"trialStatus":"COMPLETED","trialFirstPostedDate":"2018-10-15","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:28.460Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"moderate","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":3,"activeTrialCount":1},{"id":"20260402T192958-58cd6b72::gemcitabine::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"GEMCITABINE","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04297267","NCT03424005","NCT04491942","NCT03025880","NCT05007106"],"trialFound":true,"trialCompleted":true,"trialStatus":"UNKNOWN","trialFirstPostedDate":"2020-03-05","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:26.563Z","completedOutcomeClass":"positive","bestCompletedEndpointStrength":"strong","positiveCompletedTrialCount":2,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2},{"id":"20260402T192958-58cd6b72::sacituzumab_govitecan::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"SACITUZUMAB GOVITECAN","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03424005","NCT05867251","NCT04958785","NCT04639986"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:29.398Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":4},{"id":"20260402T192958-58cd6b72::talazoparib::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"TALAZOPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT04819243","NCT05288127","NCT04550494","NCT04672460","NCT03901469"],"trialFound":true,"trialCompleted":true,"trialStatus":"RECRUITING","trialFirstPostedDate":"2021-03-26","isProspective":false,"outcomeVerdict":"validated","outcomeAt":"2026-04-02T19:50:29.870Z","completedOutcomeClass":"neutral","bestCompletedEndpointStrength":"weak","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":1,"activeTrialCount":2},{"id":"20260402T192958-58cd6b72::niraparib::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"NIRAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT05232006","NCT01042379","NCT04673448","NCT05238831","NCT05169437"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2022-02-09","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:27.512Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":3},{"id":"20260402T192958-58cd6b72::olaparib::breast_cancer","analysisId":"20260402T192958-58cd6b72","recordedAt":"2026-04-02T19:29:58.844Z","drug":"OLAPARIB","disease":"breast cancer","genes":["BRCA1","BRCA2","PALB2"],"targets":["BRCA1","BRCA2","PALB2"],"confidence":"low","phase":"FDA Approved","mechanism":"","trialNctIds":["NCT07178730","NCT03801369","NCT05252390","NCT07187674","NCT04586335"],"trialFound":true,"trialCompleted":false,"trialStatus":"NOT_YET_RECRUITING","trialFirstPostedDate":"2025-09-17","isProspective":false,"outcomeVerdict":"trial_active","outcomeAt":"2026-04-02T19:50:27.989Z","completedOutcomeClass":null,"bestCompletedEndpointStrength":"unknown","positiveCompletedTrialCount":0,"negativeCompletedTrialCount":0,"mixedCompletedTrialCount":0,"neutralCompletedTrialCount":0,"activeTrialCount":2}],"calibration":{"curve":[{"confidenceBucket":0.5,"total":384,"confirmed":241,"active":86,"positiveCompleted":40,"negativeCompleted":0,"mixedCompleted":0,"neutralCompleted":201,"trialMatchRate":0.628,"researchDirectionRate":0.852,"positiveCompletedRate":0.104,"weightedCompletedOutcomeRate":0.347}],"trialMatchRate":0.628,"researchDirectionRate":0.852,"positiveCompletedRate":0.104,"weightedCompletedOutcomeRate":0.347,"overallAccuracy":null,"totalPredictions":781,"totalWithAnyTrial":327,"totalValidated":241,"totalValidatedPositive":40,"totalValidatedNegative":0,"totalValidatedMixed":0,"totalValidatedNeutral":201,"totalActive":86,"totalResolved":241,"totalConfirmed":241,"computedAt":"2026-04-03T21:47:30.648Z"},"lastChecked":"2026-04-03T20:05:58.421Z","summary":{"total":781,"validated":241,"trial_active":86,"insufficient_data":57,"unchecked":397,"confirmed":241,"negative":0,"pending":86,"trialsFound":327,"trialsCompleted":241,"positiveCompleted":40,"negativeCompleted":0,"mixedCompleted":0,"neutralCompleted":201,"avgConfidence":0}}